Phoenix Financial’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.39M | Buy |
61,276
+7,417
| +14% | +$652K | 0.07% | 125 |
|
|
2025
Q1 | $4.99M | Buy |
53,859
+2,438
| +5% | +$226K | 0.08% | 124 |
|
|
2024
Q4 | $4.52M | Sell |
51,421
-36,860
| -42% | -$3.24M | 0.06% | 140 |
|
|
2024
Q3 | $8.47M | Buy |
88,281
+6,034
| +7% | +$579K | 0.13% | 98 |
|
|
2024
Q2 | $7.61M | Sell |
82,247
-1,344
| -2% | -$124K | 0.12% | 102 |
|
|
2024
Q1 | $7.67M | Sell |
83,591
-4,953
| -6% | -$454K | 0.11% | 95 |
|
|
2023
Q4 | $7.3M | Sell |
88,544
-26,403
| -23% | -$2.18M | 0.12% | 86 |
|
|
2023
Q3 | $9.26M | Sell |
114,947
-282,969
| -71% | -$22.8M | 0.17% | 65 |
|
|
2023
Q2 | $31.3M | Buy |
397,916
+112,512
| +39% | +$8.86M | 0.64% | 37 |
|
|
2023
Q1 | $22.2M | Sell |
285,404
-1,909,604
| -87% | -$148M | 0.5% | 44 |
|
|
2022
Q4 | $171M | Sell |
2,195,008
-2,033
| -0.1% | -$158K | 3.3% | 5 |
|
|
2022
Q3 | $149M | Buy |
2,197,041
+1,715
| +0.1% | +$116K | 3.29% | 5 |
|
|
2022
Q2 | $169M | Buy |
2,195,326
+2,106,726
| +2,378% | +$162M | 3.45% | 4 |
|
|
2022
Q1 | $7.09M | Buy |
+88,600
| New | +$7.09M | 0.12% | 114 |
|